Overview
The Digital SARS-CoV-2 Antigen Rapid Test System consists of a digital test reader and test sticks. It is a lateral flow chromatographic immunoassay for the qualitative detection the nucleocapsid protein antigen from SARS-CoV-2 in nasal or nasopharyngeal swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first seven days of the onset of symptoms. The Digital SARS-CoV-2 Antigen Rapid Test System can also test specimens from asymptomatic individuals.
Benefits
Specifications
Feature |
Specifications |
|
Detection |
Nucleocapsid protein antigen |
|
Specimen |
Nasal swab specimens |
Nasopharyngeal swab specimens |
Sensitivity |
98.1% |
98.9% |
Specificity |
99.4% |
100% |
Accuracy |
98.8% |
99.6% |
Test Time |
15 minutes |
Ordering Information
Package | Format | Cata. No | Specimen |
---|---|---|---|
1 Test/Kit | Test Stick & Test Reader | L111-20235 | Nasal swab |
5 Tests/Kit | Test Stick & Test Reader | L111-20215 | Nasal swab |
7 Tests/Kit | Test Stick & Test Reader | L111-20225 | Nasal swab |
10 Tests/Kit | Test Stick & Test Reader | L111-20245 | Nasal swab |
20 Tests/Kit | Test Stick & Test Reader | L111-20255 | Nasal swab |
5 Tests/Kit | Test Stick & Test Reader | L111-20265 | Nasopharyngeal swab |
7 Tests/Kit | Test Stick & Test Reader | L111-20275 | Nasopharyngeal swab |
10 Tests/Kit | Test Stick & Test Reader | L111-20295 | Nasopharyngeal swab |
20 Tests/Kit | Test Stick & Test Reader | L111-20205 | Nasopharyngeal swab |